Betsy Gibson Emany
About Betsy Gibson Emany
Betsy Gibson Emany is the Director WW Oncology at Bristol Myers Squibb, with over 15 years of experience in pharmaceutical marketing and product management.
Current Role at Bristol Myers Squibb
Currently, Betsy Gibson Emany serves as the Director WW Oncology at Bristol Myers Squibb. In this role, she leads the launch of oncology products in global markets and is instrumental in the strategic planning and execution of marketing campaigns for oncology treatments. Her work involves regular collaboration with cross-functional teams including R&D, medical affairs, and market access to drive product success.
Professional Experience in Rheumatology
In 2019, Betsy worked as the Director, Professional Marketing Lead, Rheumatology at Bristol Myers Squibb. Although her tenure in this role was brief, lasting seven months, she contributed to professional marketing strategies for rheumatology treatments. This position allowed her to leverage her extensive marketing expertise in the specialized field of rheumatology.
Commercial Leadership in Transplant Products
From 2017 to 2020, Betsy held the position of Director, US and Worldwide Commercial Lead for Transplant (Nulojix) at Bristol Myers Squibb. During her three-year tenure, she was responsible for commercial strategies and market execution for Nulojix, a transplant medication. Her role required a deep understanding of both U.S. and global pharmaceutical markets.
Marketing Experience with Nulojix
Betsy Gibson Emany's role as Senior Product Manager, Payer Marketing for Nulojix US Marketing from 2014 to 2016 provided her with significant experience in managing payer relations and marketing strategies within the U.S. pharmaceutical market. Her contributions were crucial to the market positioning and payer acceptance of Nulojix.
Educational Background
Betsy holds a Master of Business Administration (MBA) degree from Harvard Business School, where she studied General Management from 2005 to 2007. Additionally, she earned a Bachelor of Arts (BA) degree in Economics from Colgate University, where she studied from 1996 to 2000. Her educational background has equipped her with strong management skills and a robust understanding of economic principles.